Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-554-5 | CAS number: 63-05-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Gene mutation (bacterial reverse mutation assay / Ames test, GLP, OECD TG471): negative with and without metabolic activation [Schering AG, report no. AN15, 1996-07-23]
Gene mutation (mammalian cell gene mutation test / HPRT, GLP, OECD TG 476): negative with and without metabolic activation [Harlan Cytotest Cell Research GmbH, report no. 1554600, 2013 -09 -13]
Results of genotoxicity studies published within scope of NTP (NIH, US) assessment [NTP Technical Report 560, NIH Publication No. 10-5901, September 2010]:
Gene mutation (bacterial reverse mutation assay / Ames test; S. typhimurium TA 97, TA 98, TA 100, TA 1535): negative with and without S9
Gene mutation (bacterial reverse mutation assay / Ames test; S. typhimurium TA 100 and TA 98, E. coli WP2): negative with and without S9
Chromosome aberration in rats (3-day exposure, mammalian erythrocyte micronucleus test, bone marrow erythrocytes): negative
Chromosome aberration in mice (3-month exposure, mammalian erythrocyte micronucleus test, peripheral blood erythrocytes): negative in males, equivocal in females
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 21. to 24 Nov. 1995
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- adopted May 26, 1983
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Version / remarks:
- December 29, 1992
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
- Target gene:
- Histidine locus
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and TA 102
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9-Mix from the liver of Aroclor 1254 induced male rats
- Test concentrations with justification for top dose:
- up to 5000 µg/plate
- Vehicle / solvent:
- DMSO
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: sodium azide (NaN3; for TA1535 and TA100), 4-nitro-o-phenylene-diamine (4-NOPD; for TA1537 and TA98), methylmethanesulfonate (MMS; for TA102), 2-aminoanthracene (2-AA, for all strains)
- Remarks:
- The positive controls NaN3, 4-NOPD, and MMS were used without S9 mix; the positive control 2-AA with S9 mix
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation) in triplicates; plates were incubated at 37 °C for approx. 48 hours; the frequency of revertant colonies were assessed using the Autocount (Biosys GmbH, Karben, Germany).
DETERMINATION OF CYTOTOXICITY
- Method: The background growth of the bacteria was judged visually on a light bench. Normal range of spontaneous reversion rates: TA1535 10-29, TA1537 5-28, TA98 15-57, TA100 77-189, TA102 121-293. - Evaluation criteria:
- A test article is considered positive if either a dose related increase in the number of revertants or a biological relevant increase for at least one test concentration is induced.
A test article producing neither a dose related increase in the number of revertants nor a biological relevant positive response at any one of the test points is considered nonmutagenic in this system.
A significant response is described as folIows: A test article is considered mutagenic if the number of reversions is at least twice the spontaneous reversion rate in strains TA 98 and TA 100 and TA 102 or thrice on TA 1535 and TA 1537. Also, a dose-dependent increase in the number of revertants is regarded as an indication of possibly existing mutagenic potential of the test article regardless whether the highest dose induced the criteria described above or not . - Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- (no cytotoxicity with metabolic activation, but tested up to limit concentration)
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 102
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- (no cytotoxicity with metabolic activation, but tested up to limit concentration)
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- No substantial increases in revertant colony numbers of any of the five tester strains were observed following treatment with the substance at any concentration level, either in the presence or absence of metabolic activation.
Appropriate control mutagens were used as positive controls. They showed a distinct increase in induced revertant colonies.
ADDITIONAL INFORMATION ON CYTOTOXICITY: Toxic effects, evident as a reduction in the number of revertants, occurred in all test groups in the presence or absence of metabolic activation except in strains TA 100 and TA 102 with metabolic activation. These toxic effects started to occur in strain TA 1537 at concentrations of 1000 µg/plate and above with and without metabolic activation and in strain 1535 at 1000 µg/plate in the absence and at 2500 µg/plate in the presence of S9 mix. Toxic effects were restricted to the highest concentration of the test article in strains TA 98 with and without S9 mix and TA 100 and TA 102 in the absence of metabolic activation.
The background growth of the bacteria was reduced slightly at concentrations of 1000 µg/plate and severely at 2500 and 5000 µg/plate in strains TA 1535 and TA 1537. - Conclusions:
- The substance did not show a mutagenic potential in a bacterial reverse mutation assay according to OECD TG 471 (Ames test in S. typhimurium TA98, TA1537, TA100, TA102, TA1535) when tested up to the highest recommended dose level of 5.0 mg/plate in the absence or presence of metabolic activation. Appropriate control mutagens showed the expected increases in induced revertant colonies.
- Executive summary:
The mutagenic potential of Androstendione was evaluated in a Salmonella/microsome test with the Salmonella typhimurium strains TA1535, TA1537, TA98, TA100, and TA102 in the presence and absence of S9 mix according to OECD TG 471.
The assay was performed in one experiment with and without liver microsomal activation. Each concentration, including the controls, was tested in triplicate. The test article was tested at the following concentrations: 33.3; 100.0; 333.3; 1000.0; 2500.0; and 5000.0 µg/plate.
Toxic effects, evident as a reduction in the number of revertants, occurred in all test groups with and without metabolic activation except in strains TA 100 and TA 102 with metabolic activation.
No substantial increases in revertant colony numbers of any of the five tester strains were observed following treatment with the test item at any dose level, either in the presence or absence of metabolic activation (S9 mix). There was also no tendency of higher mutation rates with increasing concentrations in the range below the generally acknowledged border of biological relevance.
Appropriate control mutagens were used as positive controls and showed a distinct increase of induced revertant colonies.
In conclusion, it can be stated that during the described mutagenicity test and under the experimental conditions reported, the test article did not induce gene mutations by base pair changes or frameshifts in the genome of the strains used.
Therefore, Androstendione is considered to be non-mutagenic in this Salmonella typhimurium reverse mutation assay.
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 22. May to 22. Aug. 2013
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- Version / remarks:
- (1997)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- mammalian cell gene mutation assay
- Target gene:
- HPRT locus
- Species / strain / cell type:
- Chinese hamster lung fibroblasts (V79)
- Details on mammalian cell type (if applicable):
- - Type and identity of media: MEM with supplements; for the selection of mutant cells the medium was supplemented with 11 µg/mL 6-thioguanine.
- Properly maintained: yes
- Periodically "cleansed" against high spontaneous background: yes
- Periodically checked for karyotype stability: yes
- Periodically checked for Mycoplasma contamination: yes - Metabolic activation:
- with and without
- Metabolic activation system:
- S9-Mix from the liver of phenobarbital/ß-naphthoflavone induced rats.
- Test concentrations with justification for top dose:
- Experiment I: treatment time 4 hours, with and without S9 mix 7.5, 15.0, 30.0, 60.0, 120.0, and 240.0 µg/mL
Experiment II: treatment time 4 hours, with S9 mix 7.5, 15.0, 30.0, 60.0, 120.0, 180.0, and 240.0 µg/mL; treatment time 24 hours, without S9 mix 1.89, 3.75, 7.5, 15.0, 30.0, 60.0, 90.0, and 120.0 µg/mL. - Vehicle / solvent:
- DMSO
- Justification for choice of solvent/vehicle: The solvent was chosen due to its solubility properties and its relative non-toxicity to the cell cultures. - Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: ethylmethanesulfonate (EMS; 1.2 mM), 7,12-dimethylbenzanthracene (DMBA; 4.3 µM)
- Remarks:
- EMS was used without and DMBA with metabolic activation
- Details on test system and experimental conditions:
- PRE-TEST: Test item concentrations ranged between 15.0 ¿g/mL and 1920 ¿g/mL in the pre-experiment. As result no relevant toxic effect occurred up to the maximum concentration tested with and without metabolic activation following 4 hour treatment. A transient reduction of the cloning efficiency to 44.1 % at 480 ¿g/mL without metabolic activation was judged as precipitation artefact rather than true cytotoxicity as the cloning efficiency was back to normal at higher concentrations. Following 24 hours treatment without metabolic activation cytotoxic effects occurred at 120 ¿g/mL and above.
METHOD OF APPLICATION: in medium
Approximately 1.5×10exp6 (single culture) and 5×102 cells (in duplicate) were seeded in plastic culture flasks. The cells were grown for 24 hours prior to treatment. After 24 hours the medium was replaced with serum-free medium containing the test item, either without S9 mix or with 50 ¿l/mL S9 mix. Concurrent solvent and positive controls were treated in parallel. After 4 hours this medium was replaced with complete medium following two washing steps with "saline G". In the second experiment the cells were exposed to the test item for 24 hours in complete medium, supplemented with 10 % FBS, in the absence of metabolic activation.
Three or four days after treatment 1.5×10exp6 cells per experimental point were sub-cultivated in 175 cm² flasks containing 30 mL medium. Following the expression time of 7 days five 80 cm² cell culture flasks were seeded with about 3 - 5×10exp5 cells each in medium containing 6-TG. Two additional 25 cm² flasks were seeded with approx. 500 cells each in non-selective medium to determine the viability.
The cultures were incubated at 37 °C in a humidified atmosphere with 1.5 % CO2 for about 8 days. The colonies were stained with 10 % methylene blue in 0.01 % KOH solution.
The stained colonies with more than 50 cells were counted. In doubt the colony size was checked with a preparation microscope.
DURATION
- Exposure duration: 4 hours
- Expression time (cells in growth medium): 7 days
- Selection time: 8 days
DETERMINATION OF CYTOTOXICITY
- Method: cloning efficiency - Evaluation criteria:
- A test item is classified as positive if it induces either a concentration-related increase of the mutant frequency or a reproducible and positive response at one of the test points. A test item producing neither a concentration-related increase of the mutant frequency nor a reproducible positive response at any of the test points is considered non-mutagenic in this system.
A positive response is described as follows: A test item is classified as mutagenic if it reproducibly induces a mutation frequency that is three times above the spontaneous mutation frequency at least at one of the concentrations in the experiment. The test item is classified as mutagenic if there is a reproducible concentration-related increase of the mutation frequency. Such evaluation may be considered also in the case that a threefold increase of the mutant frequency is not observed. However, in a case by case evaluation this decision depends on the level of the corresponding solvent control data. If there is by chance a low spontaneous mutation rate within the laboratory¿s historical control data range, a concentration-related increase of the mutations within this range has to be discussed. The variability of the mutation rates of solvent controls within all experiments of this study was also taken into consideration. - Statistics:
- A linear regression (least squares) was performed to assess a possible dose dependent increase of mutant frequencies.
- Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- No substantial and reproducible dose dependent increase of the mutation frequency was observed in both main experiments. Appropriate reference mutagens, used as positive controls, induced a distinct increase in mutant colonies and thus, showed the sensitivity of the test system and the activity of the metabolic activation system.
TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH and osmolarity: There was no relevant shift of pH and osmolarity of the medium even at the maximum concentration of the test item.
- Water solubility: The maximum concentration of the pre-experiments (1920 ¿g/mL) was based on the solubility properties of the test item in DMSO and aqueous medium.
- Precipitation: No precipitation of the test item was observed up to the maximum analyzable concentration in both main experiments. In the pre-experiments precipitation occurred at 120 ¿g/mL and above after 4 hours treatment with and without metabolic activation, and at 480 ¿g/mL and above following 24 hours treatment without metabolic activation.
ADDITIONAL INFORMATION ON CYTOTOXICITY:
Cytotoxic effects indicated by a relative cloning efficiency I or relative cell density below 50 % of the corresponding solvent control were noted at 120 ¿g/mL in the first main experiment without metabolic activation. In the presence of metabolic activation no cytotoxicity was observed at the maximum analyzable concentration of 120 ¿g/mL. At the next higher concentration of 240 ¿g/mL exceedingly severe cytotoxic effects precluded analysis of any data on mutagenicity. In the second experiment cytotoxicity as described above occurred at 180 ¿g/mL with and at 120 ¿g/mL without metabolic activation. The recommended cytotoxic range of approximately 10-20 % relative cloning efficiency I or relative cell density was covered with and without metabolic activation. - Conclusions:
- negative
- Executive summary:
Androstendion was tested in an in vitro gene mutation assay in V79 cells (HPRT) according to OECD TG 476. The assay was performed in two independent experiments. The cells were exposed to the test item for 4 hours in the first experiment with and without metabolic activation. The second experiment was performed with a treatment time of 4 hours with and 24 hours without metabolic activation.
The maximum concentration of the pre-experiments (1920 μg/mL) was based on the solubility properties of the test item in DMSO and aqueous medium. The dose range of experiment I was limited by precipitation observed in the pre-experiment. The dose range of experiment II without metabolic activation was based on cytotoxic effects noted in the pre-experiment. The dose range of experiment II with metabolic activation was adjusted to cytotoxicity and precipitation observed in experiment I.
No substantial and reproducible dose dependent increase of the mutation frequency was observed in both main experiments.
Appropriate reference mutagens, used as positive controls, induced a distinct increase in mutant colonies and thus, showed the sensitivity of the test system and the activity of the metabolic activation system.
In conclusion it can be stated that under the experimental conditions reported the test item did not induce gene mutations at the HPRT locus in V79 cells.
Therefore, Androstendion is considered to be non-mutagenic in this HPRT assay.
Referenceopen allclose all
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Link to relevant study records
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline study (supervised by NTP); published data without detailed documentation
- Qualifier:
- according to guideline
- Guideline:
- other: NTP laboratory health and safety guidelines
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Version / remarks:
- 1983
- Principles of method if other than guideline:
- The study was performed according to standard three-exposure protocol as described by Shelby et al., Environ. Mol. Mutagen. 21, 1993, 160-179.
Cited from report: "These are the basic guidelines for arriving at an overall assay result for assays performed by the National Toxicology Program. Statistical as well as biological factors are considered. For an individual assay, the statistical procedures for data analysis have been described in the preceding protocols. There have been instances, however, in which multiple aliquots of a chemical were tested in the same assay, and different results were obtained among aliquots and/or among laboratories. Results from more than one aliquot or from more than one laboratory are not simply combined into an overall result. Rather, all the data are critically evaluated, particularly with regard to pertinent protocol variations, in determining the weight of evidence for an overall conclusion of chemical activity in an assay. In addition to multiple aliquots, the in vitro assays have another variable that must be considered in arriving at an overall test result. In vitro assays are conducted with and without exogenous metabolic activation. Results obtained in the absence of activation are not combined with results obtained in the presence of activation; each testing condition is evaluated separately." The summary table in the Abstract of the Technical Report presents a result that represents a scientific judgement of the overall evidence for activity of the chemical in an assay. - GLP compliance:
- yes
- Type of assay:
- micronucleus assay
- Specific details on test material used for the study:
- no data in NTP TR 560
- Species:
- rat
- Strain:
- Fischer 344
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Strain: F344/N
no further data in NTP TR 560 - Route of administration:
- oral: gavage
- Vehicle:
- - Vehicle(s)/solvent(s) used: corn oil
- Details on exposure:
- Preliminary range-finding studies were performed. Factors affecting dose selection included chemical solubility and toxicity and the extent of cell cycle delay induced by androstenedione exposure.
- Duration of treatment / exposure:
- 3 days; The animals were killed 24 hours after the third dosing and bone marrow samples prepared.
- Frequency of treatment:
- three times at 24-hour interval
- Post exposure period:
- 24 hours
- Remarks:
- Doses / Concentrations:
312.5 and 625 mg/kg bw
Basis:
actual ingested
exposure: 3 days - No. of animals per sex per dose:
- 5
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- The positive control animals received injections of cyclophosphamide (15 or 25 mg/kg).
- Tissues and cell types examined:
- The animals were killed 24 hours after the third dosing, and blood smears were prepared from bone marrow cells obtained from the femurs. Air-dried smears were fixed and stained. 2000 polychromatic erythrocytes (PCEs; reticulocytes) were scored for the frequency of micronucleated cells in each of up to five animals per dose group. In addition, the percentage of PCEs among the total erythrocyte population in the bone marrow was scored for each dose group as a measure of toxicity.
- Evaluation criteria:
- In the micronucleus test, an individual trial is considered positive if the trend test P value is less than or equal to 0.025 or if the P value for any single dosed group is less than or equal to 0.025 divided by the number of dosed groups. A final call of positive for micronucleus induction is preferably based on reproducibly positive trials. Ultimately, the final call is determined by the scientific staff after considering the results of statistical analyses, the reproducibility of any effects observed, and the magnitudes of those effects.
- Statistics:
- The frequency of micronucleated cells among PCEs was analyzed by a statistical software package that tested for increasing trend over dose groups with a one-tailed Cochran-Armitage trend test, followed by pairwise comparisons between each dosed group and the control group (Integrated Laboratory Systems (ILS), Micronucleus Data Management and Statistical Analysis Software, Version 1.4. ILS, Inc., P.O. Box 13501, Research Triangle Park, NC 277071990, 1990). In the presence of excess binomial variation, as detected by a binomial dispersion test, the binomial variance of the Cochran-Armitage test was adjusted upward in proportion to the excess variation.
- Sex:
- male
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- In vivo, no significant increases in the frequencies of micronucleated PCEs (reticulocytes) were observed in bone marrow of male F344/N rats administered androstenedione (312.5 or 625 mg/kg) by gavage once daily for 3 days. No significant changes in the percentages of PCEs among total erythrocytes were seen in the rats, suggesting no androstenedione-associated toxicity in the bone marrow.
Induction of Micronuclei in Bone Marrow Polychromatic Erythrocytes of Male Rats Treated
with Androstenedione by Gavage (a)
Compound Dose
(mg/kg) Number of Male Rats
with Erythrocytes Scored Micronucleated PCEs/
1,000 PCEs (b) Pairwise p value (c) PCE (b) (%)
Corn oil (d) 0 3 0.33 ± 0.17 5.200 ± 0.15
Androstenedione 312.5 5 0.40 ± 0.10 0.4165 5.120 ± 0.34
625 5 0.50 ± 0.39 0.3128 4.420 ± 0.60
P=0.304 (e)
Cyclophosphamide (f) 15 5 24.00 ± 2.47 0.0000 1.180 ± 0.17
25 4 19.17 ± 2.37 0.0000 0.700 ± 0.08
a Study was performed at ILS, Inc. The detailed protocol is presented by Shelby et al. (1993).
PCE=polychromatic erythrocyte
b Mean ± standard error
c Pairwise comparison with the vehicle control; dosed group values are significant at P#0.013; positive control values are significant at P=0.05 (ILS, 1990)
d Vehicle control
e Significance of micronucleated PCEs/1,000 PCEs tested by the one-tailed trend test, significant at P#0.025 (ILS, 1990).
f Positive control - Conclusions:
- negative
- Executive summary:
The genetic toxicity of androstenedione was assessed by testing the ability of the substance to induce mutations micronucleated erythrocytes in rat bone.
Male F344/N rats received androstenedion dissolved in corn oil by gavage three times at 24-hour intervals; vehicle control animals received corn oil only. The positive control animals received injections of cyclophosphamide (15 or 25 mg/kg). The animals were killed 24 hours after the third dosing, and blood smears were prepared from bone marrow cells obtained from the femurs. Air-dried
smears were fixed and stained; 2,000 polychromatic erythrocytes (PCEs; reticulocytes) were scored for the frequency of micronucleated cells in each of up to five animals per dose group. In addition, the percentage of PCEs among the total erythrocyte population in the bone marrow was scored for each dose group as a measure of toxicity.
No significant increases in the frequencies of micronucleated PCEs (reticulocytes) were observed in bone marrow of male F344/N rats administered androstenedione (312.5 or 625 mg/kg) by gavage once daily for 3 days.
No significant changes in the percentages of PCEs among total erythrocytes were seen in this study, suggesting no androstenedione-associated toxicity in the bone marrow.
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline study (supervised by NTP); published data without detailed documentation
- Qualifier:
- according to guideline
- Guideline:
- other: NTP laboratory health and safety guidelines
- Principles of method if other than guideline:
- A detailed discussion of this assay is presented by MacGregor et al., Fundam. Appl. Toxicol. 14, 1990, 513-522.
Cited from report: "These are the basic guidelines for arriving at an overall assay result for assays performed by the National Toxicology Program. Statistical as well as biological factors are considered. For an individual assay, the statistical procedures for data analysis have been described in the preceding protocols. There have been instances, however, in which multiple aliquots of a chemical were tested in the same assay, and different results were obtained among aliquots and/or among laboratories. Results from more than one aliquot or from more than one laboratory are not simply combined into an overall result. Rather, all the data are critically evaluated, particularly with regard to pertinent protocol variations, in determining the weight of evidence for an overall conclusion of chemical activity in an assay. In addition to multiple aliquots, the in vitro assays have another variable that must be considered in arriving at an overall test result. In vitro assays are conducted with and without exogenous metabolic activation. Results obtained in the absence of activation are not combined with results obtained in the presence of activation; each testing condition is evaluated separately." The summary table in the Abstract of the Technical Report presents a result that represents a scientific judgement of the overall evidence for activity of the chemical in an assay. - GLP compliance:
- yes
- Type of assay:
- micronucleus assay
- Specific details on test material used for the study:
- - Name of test material (as cited in study report): Androstendione
- Lot/batch No.: H408
- Purity: > 98 %
- Stability under test conditions: The stability of the substance in the formulation was analytically verified for at least 35 days (sealed amber glass bottles; 5 °C). - Species:
- mouse
- Strain:
- not specified
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
no further data in NTP TR 560 - Route of administration:
- oral: gavage
- Vehicle:
- methylcellulose
- Duration of treatment / exposure:
- 3 months
- Frequency of treatment:
- once daily
- Post exposure period:
- 24 hours
- Remarks:
- Doses / Concentrations:
1 to 50 mg/kg bw
Basis:
actual ingested
exposure: 3 month - No. of animals per sex per dose:
- 5
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- none
- Tissues and cell types examined:
- At the end of the 3-month toxicity study (see chapter repeated dose toxicity for further results), peripheral blood samples were obtained from male and female mice. Smears were immediately prepared and fixed in absolute methanol. The methanol-fixed slides were stained with acridine orange and coded. Slides were scanned to determine the frequency of micronuclei in 2000 normochromatic erythrocytes (NCEs) in each of five animals per dose group. In addition, the percentage of PCEs among the total erythrocyte population was determined as a measure of bone marrow toxicity.
- Evaluation criteria:
- In the micronucleus test, an individual trial is considered positive if the trend test P value is less than or equal to 0.025 or if the P value for any single dosed group is less than or equal to 0.025 divided by the number of dosed groups. A final call of positive for micronucleus induction is preferably based on reproducibly positive trials. Ultimately, the final call is determined by the scientific staff after considering the results of statistical analyses, the reproducibility of any effects observed, and the magnitudes of those effects.
- Statistics:
- The results were tabulated as the mean of the pooled results from all animals within a treatment group plus or minus the standard error of the mean. The frequency of micronucleated cells among NCEs was analyzed by a statistical software package that tested for increasing trend over dose groups with a one-tailed Cochran-Armitage trend test, followed by pairwise comparisons between each dosed group and the control group (Integrated Laboratory Systems (ILS), Micronucleus Data Management and Statistical Analysis Software, Version 1.4. ILS, Inc., P.O. Box 13501, Research Triangle Park, NC 277071990, 1990). In the presence of excess binomial variation, as detected by a binomial dispersion test, the binomial variance of the Cochran-Armitage test was adjusted upward in proportion to the excess variation.
- Sex:
- male
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- not applicable
- Positive controls validity:
- not applicable
- Sex:
- female
- Genotoxicity:
- ambiguous
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- not applicable
- Positive controls validity:
- not applicable
- Additional information on results:
- Following 3 months of androstenedione administration (1 to 50 mg/kg) by gavage, no increase in the frequency of micronucleated NCEs was seen in peripheral blood samples from male B6C3F1 mice. In female mice, a small increase in the frequency of micronucleated NCEs was observed at the highest dose tested (50 mg/kg); although not significantly elevated above the vehicle control (P=0.0142), this increase resulted in a significant trend (P=0.001), and the test in female mice was judged to be equivocal.
No significant changes in the percentages of PCEs among total erythrocytes were seen in mice, suggesting no androstenedione-associated toxicity in the bone marrow. - Conclusions:
- equivocal
- Executive summary:
The genetic toxicity of androstenedione was assessed by testing the ability of the substance to induce increases in the frequency of micronucleated erythrocytes in mouse peripheral blood.
At the end of the 3-month toxicity study in male and female B6C3F1 mice, peripheral blood samples were obtained from male and female mice. Smears were immediately prepared and fixed in absolute methanol. The methanol-fixed slides were stained with acridine orange and coded. Slides were scanned to determine the frequency of micronuclei in 2,000 normochromatic erythrocytes (NCEs) in each of five animals per dose group. In addition, the percentage of PCEs among the total erythrocyte population was determined as a measure of bone marrow toxicity.
Following 3 months of androstenedione administration (1 to 50 mg/kg) by gavage, no increase in the
frequency of micronucleated NCEs was seen in peripheral blood samples from male B6C3F1 mice. In
female mice, a small increase in the frequency of micronucleated NCEs was observed at the highest dose tested (50 mg/kg); although not significantly elevated above the vehicle control (P=0.0142), this increase resulted in a significant trend (P=0.001), and the test in female mice was judged to be equivocal.
No significant changes in the percentages of PCEs among total erythrocytes were seen in this study, suggesting no androstenedione-associated toxicity in the bone marrow.
Referenceopen allclose all
Frequency of Micronuclei in Peripheral Blood Erythrocytes of Mice Following Gavage Administration of Androstenedione for 3 Months (a)
Compound | Dose (mg/kg) | Number of Male Rats with Erythrocytes Scored | Micronucleated PCEs/ 1,000 NCEs (b) | Pairwise p value (c) | PCE (b) (%) |
Male |
|
|
|
|
|
Methylcellulose (d) | 0 | 5 | 2.60 ± 0.51 |
| 2.860 ± 0.19 |
Androstenedione | 1 | 5 | 2.90 ± 0.62 | 0.3427 | 2.500 ± 0.37 |
| 5 | 5 | 2.80 ± 0.30 | 0.3926 | 3.020 ± 0.18 |
| 10 | 5 | 2.70 ± 0.54 | 0.4453 | 3.020 ± 0.20 |
| 20 | 5 | 2.40 ± 0.46 | 0.6115 | 2.920 ± 0.18 |
| 50 | 5 | 2.10 ± 0.10 | 0.7674 | 2.540 ± 0.29 |
|
|
| P=0.880 (e) |
|
|
Female |
|
|
|
|
|
Methylcellulose | 0 | 5 | 1.60 ± 0.43 |
| 2.820 ± 0.24 |
Androstenedione | 1 | 5 | 1.30 ± 0.20 | 0.7114 | 2.860 ± 0.28 |
| 5 | 5 | 1.40 ± 0.29 | 0.6426 | 3.300 ± 0.29 |
| 10 | 5 | 2.00 ± 0.57 | 0.2523 | 3.200 ± 0.18 |
| 20 | 5 | 1.30 ± 0.12 | 0.7114 | 3.260 ± 0.27 |
| 50 | 5 | 3.10 ± 0.40 | 0.0142 | 2.640 ± 0.14 |
|
|
| P=0.001 |
|
|
a Study was performed at ILS, Inc. The detailed protocol is presented by MacGregor et al. (1990).
PCE = polychromatic erythrocyte; NCE = normochromatic erythrocyte.
b Mean ± standard error
c Pairwise comparison with the vehicle control group; significant at P#0.005 (ILS, 1990)
d Vehicle control
e Significance of micronucleated NCEs/1,000 NCEs tested by the one-tailed trend test, significant at P</=0.025 (ILS, 1990)
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
In vitro studies
The mutagenic potential of Androstendion was evaluated in a Salmonella/microsome test with the Salmonella typhimurium strains TA1535, TA1537, TA98, TA100, and TA102 in the presence and absence of S9 mix according to OECD TG 471.
The assay was performed in one experiment with and without liver microsomal activation. Each concentration, including the controls, was tested in triplicate. The test article was tested at the following concentrations: 33.3; 100.0; 333.3; 1000.0; 2500.0; and 5000.0 µg/plate.
Toxic effects, evident as a reduction in the number of revertants, occurred in all test groups with and without metabolic activation except in strains TA 100 and TA 102 with metabolic activation.
No substantial increases in revertant colony numbers of any of the five tester strains were observed following treatment with the test item at any dose level, either in the presence or absence of metabolic activation (S9 mix). There was also no tendency of higher mutation rates with increasing concentrations in the range below the generally acknowledged border of biological relevance.
Appropriate control mutagens were used as positive controls and showed a distinct increase of induced revertant colonies.
In conclusion, it can be stated that during the described mutagenicity test and under the experimental conditions reported, the test article did not induce gene mutations by base pair changes or frameshifts in the genome of the strains used.
Therefore, Androstendion is considered to be non-mutagenic in this Salmonella typhimurium reverse mutation assay (Reimann, 1996).
Androstendion was tested in an in vitro gene mutation assay in V79 cells (HPRT) according to OECD TG 476. The assay was performed in two independent experiments. The cells were exposed to the test item for 4 hours in the first experiment with and without metabolic activation. The second experiment was performed with a treatment time of 4 hours with and 24 hours without metabolic activation.
The maximum concentration of the pre-experiments (1920 μg/mL) was based on the solubility properties of the test item in DMSO and aqueous medium. The dose range of experiment I was limited by precipitation observed in the pre-experiment. The dose range of experiment II without metabolic activation was based on cytotoxic effects noted in the pre-experiment. The dose range of experiment II with metabolic activation was adjusted to cytotoxicity and precipitation observed in experiment I.
No substantial and reproducible dose dependent increase of the mutation frequency was observed in both main experiments.
Appropriate reference mutagens, used as positive controls, induced a distinct increase in mutant colonies and thus, showed the sensitivity of the test system and the activity of the metabolic activation system.
In conclusion it can be stated that under the experimental conditions reported the test item did not induce gene mutations at the HPRT locus in V79 cells.
Therefore, Androstendion is considered to be non-mutagenic in this HPRT assay (Wollny, 2013).
Supporting data are reported in the NTP assessment [NTP Technical Report 560, NIH Publication No. 10-5901, September 2010]:
Androstenedione was not mutagenic in a bacterial mutation assay conducted with and without exogenous metabolic activation and at concentrations up to 10000 µg/plate for each tester strain (S. typhimurium TA 97, TA 98, TA 100, and TA 1535).
The assay was conducted as part of a NTP testing program and has to be seen as a whole together with a second indepently performed bacterial mutation assay. Therefore, only 4 relevant tester strains were used here, for results on E.coli WP2 see other endpoint study record (Ames test - part two, NTP, 2010).
Androstenedione was not mutagenic in a bacterial mutation assay conducted with and without exogenous metabolic activation and at concentrations up to 3500 µg/plate for S. typhimurium TA 100, up to 7500 µg/plate for S. typhimurium TA 98, and up to 10000 µg/plate for E. coli WP2.
The assay was conducted as part of a NTP testing program and has to be seen as a whole together with a second indepently performed bacterial mutation assay. Therefore, only 3 relevant tester strains were used here, for results on S. typhimurium TA 97, TA 98, TA 100, and TA 1535 see other endpoint study record (Ames test - part one, NTP, 2010).
In vivo studies
The genetic toxicity of androstenedione was assessed by testing the ability of the substance to induce mutations micronucleated erythrocytes in rat bone marrow and increases in the frequency of micronucleated erythrocytes in mouse peripheral blood.
Male F344/N rats received androstenedion dissolved in corn oil by gavage three times at 24-hour intervals; vehicle control animals received corn oil only. The positive control animals received injections of cyclophosphamide (15 or 25 mg/kg). The animals were killed 24 hours after the third dosing, and blood smears were prepared from bone marrow cells obtained from the femurs. Air-dried
smears were fixed and stained; 2,000 polychromatic erythrocytes (PCEs; reticulocytes) were scored for the frequency of micronucleated cells in each of up to five animals per dose group. In addition, the percentage of PCEs among the total erythrocyte population in the bone marrow was scored for each dose group as a measure of toxicity.
No significant increases in the frequencies of micronucleated PCEs (reticulocytes) were observed in bone marrow of male F344/N rats administered androstenedione (312.5 or 625 mg/kg) by gavage once daily for 3 days.
At the end of the 3-month toxicity study in male and female B6C3F1 mice, peripheral blood samples were obtained from male and female mice. Smears were immediately prepared and fixed in absolute methanol. The methanol-fixed slides were stained with acridine orange and coded. Slides were scanned to determine the frequency of micronuclei in 2,000 normochromatic erythrocytes (NCEs) in each of five animals per dose group. In addition, the percentage of PCEs among the total erythrocyte population was determined as a measure of bone marrow toxicity.
Following 3 months of androstenedione administration (1 to 50 mg/kg) by gavage, no increase in the
frequency of micronucleated NCEs was seen in peripheral blood samples from male B6C3F1 mice. In
female mice, a small increase in the frequency of micronucleated NCEs was observed at the highest dose tested (50 mg/kg); although not significantly elevated above the vehicle control (P=0.0142), this increase resulted in a significant trend (P=0.001), and the test in female mice was judged to be equivocal.
No significant changes in the percentages of PCEs among total erythrocytes were seen in either the rats or mice, suggesting no androstenedione-associated toxicity in the bone marrow.
Justification for classification or non-classification
Overall, no classification required for genetic toxicity according to Regulation (EC) 1272/2008.
This is in accordance with German legislation for classification of androgenic steroids (See argumentation for the assessment of steroid hormones, Technical Rule for Hazardous substances 905; elaborated by the German Committee on Hazardous Substances (AGS) and published by the German Federal Ministry of Labour and Social Affairs, version of 2008/2005/1999, only available in German, http://www.baua.de/de/Themen-von-A-Z/Gefahrstoffe/TRGS/Begruendungen-905-906.html).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.